BR9915235A - ácidos hialurÈnicos reticulados e usos médicos dos mesmos - Google Patents

ácidos hialurÈnicos reticulados e usos médicos dos mesmos

Info

Publication number
BR9915235A
BR9915235A BR9915235-5A BR9915235A BR9915235A BR 9915235 A BR9915235 A BR 9915235A BR 9915235 A BR9915235 A BR 9915235A BR 9915235 A BR9915235 A BR 9915235A
Authority
BR
Brazil
Prior art keywords
hyaluronic acids
cross
linked hyaluronic
medical uses
prostheses
Prior art date
Application number
BR9915235-5A
Other languages
English (en)
Inventor
Rolando Barbucci
Roberto Rapuoli
Original Assignee
Aquisitio S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11381033&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9915235(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aquisitio S P A filed Critical Aquisitio S P A
Publication of BR9915235A publication Critical patent/BR9915235A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

Patente de Invenção: <B>"áCIDOS HIALURÈNICOS RETICULADOS E USOS MéDICOS DOS MESMOS"<D>. A presente invenção refere-se a novos ácidos hialurónicos reticulados obtidos através de grupos carboxílicos ativados de ácido hialurónico nativo linear, de fonte extrativa ou biossintética, com uma poliamina, particularmente uma alquil diamina linear. Os ácidos hialurónicos reticulados da invenção podem opcionalmente ser sulfatados ou hemissucinilados e são úteis como substitutos de fluido sinovial, humor vítreo, medicamentos em forma de matrizes de liberação controlada, como agentes de cicatrização e antiadesivos, e para a preparação de prótese vascular, orgãos bioíbridos, dispositivos de cicatrização, composições oftálmicas e otológicas, próteses, implantes e dispositivos médicos.
BR9915235-5A 1998-11-11 1999-11-08 ácidos hialurÈnicos reticulados e usos médicos dos mesmos BR9915235A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998MI002440A IT1303735B1 (it) 1998-11-11 1998-11-11 Acidi ialuronici reticolati e loro usi medici.
PCT/EP1999/008481 WO2000027887A2 (en) 1998-11-11 1999-11-08 Cross-linked hyaluronic acids and medical uses thereof

Publications (1)

Publication Number Publication Date
BR9915235A true BR9915235A (pt) 2001-07-24

Family

ID=11381033

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9915235-5A BR9915235A (pt) 1998-11-11 1999-11-08 ácidos hialurÈnicos reticulados e usos médicos dos mesmos

Country Status (24)

Country Link
US (1) US6831172B1 (pt)
EP (1) EP1144459B2 (pt)
JP (1) JP2002529550A (pt)
KR (1) KR100674177B1 (pt)
CN (1) CN1131241C (pt)
AT (1) ATE225371T1 (pt)
AU (1) AU757102B2 (pt)
BR (1) BR9915235A (pt)
CA (1) CA2350667A1 (pt)
CZ (1) CZ296842B6 (pt)
DE (1) DE69903351T3 (pt)
DK (1) DK1144459T4 (pt)
ES (1) ES2184521T5 (pt)
HK (1) HK1041011B (pt)
HU (1) HU229668B1 (pt)
IL (1) IL143063A0 (pt)
IT (1) IT1303735B1 (pt)
NO (1) NO20012315L (pt)
NZ (1) NZ511306A (pt)
PT (1) PT1144459E (pt)
RU (1) RU2230752C2 (pt)
TR (1) TR200101324T2 (pt)
WO (1) WO2000027887A2 (pt)
ZA (1) ZA200103799B (pt)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD980037A1 (it) * 1998-02-25 1999-08-25 Fidia Advanced Biopolymers Srl Acido ialuronico solfatato e i suoi derivati legati covalentemente a polimeri sintetici pe la preparazione di biomateriali e per il rivesti
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
US6307487B1 (en) 1998-09-23 2001-10-23 Digital Fountain, Inc. Information additive code generator and decoder for communication systems
US7068729B2 (en) 2001-12-21 2006-06-27 Digital Fountain, Inc. Multi-stage code generator and decoder for communication systems
IT1303738B1 (it) * 1998-11-11 2001-02-23 Aquisitio S P A Processo di reticolazione di polisaccaridi carbossilati.
CA2370003C (en) 1999-01-13 2008-08-19 Tracey Brown A composition and method for the enhancement of the efficacy of drugs
KR100338179B1 (ko) * 2000-05-08 2002-05-24 김범철 안질환 치료용 약물 전달을 위한 그래프트 중합체 및 그제조방법
AUPQ879500A0 (en) * 2000-07-14 2000-08-10 Meditech Research Limited Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
US9066919B2 (en) * 2000-07-14 2015-06-30 Alchemia Oncology Pty Limited Hyaluronan as a chemo-sensitizer in the treatment of cancer
KR100375299B1 (ko) * 2000-10-10 2003-03-10 주식회사 엘지생명과학 히알루론산의 가교결합형 아마이드 유도체와 이의 제조방법
US7335383B2 (en) 2001-01-16 2008-02-26 The Regents Of The University Of Michigan Generation of nitric oxide in vivo from nitrite, nitrate or nitrosothiols endogenous in blood
WO2002056904A1 (en) * 2001-01-16 2002-07-25 The Regents Of The University Of Michigan Biocatalytic and biomimetic generation of nitric oxide in situ at substrate/blood interfaces
US7128904B2 (en) 2001-01-16 2006-10-31 The Regents Of The University Of Michigan Material containing metal ion ligand complex producing nitric oxide in contact with blood
CA2458856C (en) * 2001-08-27 2011-02-15 Meditech Research Limited Improved therapeutic protocols
US9240810B2 (en) 2002-06-11 2016-01-19 Digital Fountain, Inc. Systems and processes for decoding chain reaction codes through inactivation
KR20040009891A (ko) * 2002-07-26 2004-01-31 주식회사 엘지생명과학 히알루론산의 유도체 겔 및 그 제조방법
US6909383B2 (en) 2002-10-05 2005-06-21 Digital Fountain, Inc. Systematic encoding and decoding of chain reaction codes
JP2006503657A (ja) * 2002-10-25 2006-02-02 エッセンシア・バイオシステムズ・インコーポレイテッド 亜鉛を用いる埋め込み可能な医療装置
FR2850282B1 (fr) 2003-01-27 2007-04-06 Jerome Asius Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
WO2004081055A1 (ja) * 2003-02-21 2004-09-23 Terumo Kabushiki Kaisha 架橋性多糖誘導体、その製造方法、架橋性多糖組成物および医療用処置材
JP2004262777A (ja) * 2003-02-27 2004-09-24 Shiseido Co Ltd アセチル化ヒアルロン酸含有眼用医薬組成物
BR0318237A (pt) * 2003-04-04 2006-04-04 Bayco Tech Ltd sonda vascular
EP2722995B1 (en) 2003-10-06 2023-04-19 QUALCOMM Incorporated Soft-Decision Decoding of Multi-Stage Chain Reaction Codes
EP1681306B1 (en) * 2003-10-29 2013-02-20 Teijin Limited Hyaluronic acid compound, hydrogel thereof and material for treating joint
US20090148527A1 (en) * 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
KR101161193B1 (ko) 2004-05-07 2012-07-02 디지털 파운튼, 인크. 파일 다운로드 및 스트리밍 시스템
ITMI20041373A1 (it) 2004-07-09 2004-10-09 Lima Lto S P A N-metil-ammidi di carbossimetilcellulosa acido alginico o carbossimetalamido
WO2006028110A1 (ja) * 2004-09-07 2006-03-16 Chugai Seiyaku Kabushiki Kaisha 水溶性ヒアルロン酸修飾物の製造方法
CN101056891B (zh) * 2004-11-15 2010-05-26 株式会社资生堂 交联透明质酸凝胶的制备方法
PL1817347T3 (pl) * 2004-11-24 2017-10-31 Albumedix As Sposób sieciowania kwasu hialuronowego za pomocą diwinylosulfonu
CN101133102A (zh) * 2004-12-30 2008-02-27 诺维信生物聚合物公司 与α-羟酸的聚合物连接的透明质酸
ITPD20050056A1 (it) * 2005-03-02 2006-09-03 Fidia Farmaceutici Derivati ammidici del'acido ialuronico in osteoartrosi
TW200643033A (en) * 2005-03-08 2006-12-16 Chugai Pharmaceutical Co Ltd Conjugate of water-soluble modified hyaluronic acid and glp-1 analogue
US7676735B2 (en) 2005-06-10 2010-03-09 Digital Fountain Inc. Forward error-correcting (FEC) coding and streaming
CA2616607C (en) 2005-07-27 2015-06-02 Alchemia Oncology Pty Limited Therapeutic protocols using hyaluronan
JP5627181B2 (ja) 2005-09-07 2014-11-19 アルケミア オンコロジー ピーティーワイ リミテッド ヒアルロナンおよび治療用抗体を含む治療用組成物ならびに治療方法
US7879818B2 (en) * 2005-12-23 2011-02-01 Janos Borbely Hyaluronic acid-based cross-linked nanoparticles
KR100737954B1 (ko) * 2006-01-03 2007-07-13 고려대학교 산학협력단 조직재생을 위한 히알루론산-기초된 주사형 하이드로겔
JP5550834B2 (ja) 2006-02-13 2014-07-16 デジタル ファウンテン， インコーポレイテッド 可変ｆｅｃオーバヘッド及び保護期間を利用したストリーミング及びバッファリング
US9270414B2 (en) 2006-02-21 2016-02-23 Digital Fountain, Inc. Multiple-field based code generator and decoder for communications systems
WO2007101243A1 (en) * 2006-02-28 2007-09-07 Novozymes Biopolymer A/S Derivatives of hyaluronic acids
US7674781B2 (en) * 2006-04-28 2010-03-09 Heather Sheardown Hyaluronic acid-retaining polymers
US7971129B2 (en) 2006-05-10 2011-06-28 Digital Fountain, Inc. Code generator and decoder for communications systems operating using hybrid codes to allow for multiple efficient users of the communications systems
US9419749B2 (en) 2009-08-19 2016-08-16 Qualcomm Incorporated Methods and apparatus employing FEC codes with permanent inactivation of symbols for encoding and decoding processes
US9209934B2 (en) 2006-06-09 2015-12-08 Qualcomm Incorporated Enhanced block-request streaming using cooperative parallel HTTP and forward error correction
US9178535B2 (en) 2006-06-09 2015-11-03 Digital Fountain, Inc. Dynamic stream interleaving and sub-stream based delivery
US9386064B2 (en) 2006-06-09 2016-07-05 Qualcomm Incorporated Enhanced block-request streaming using URL templates and construction rules
US9380096B2 (en) 2006-06-09 2016-06-28 Qualcomm Incorporated Enhanced block-request streaming system for handling low-latency streaming
US9432433B2 (en) 2006-06-09 2016-08-30 Qualcomm Incorporated Enhanced block-request streaming system using signaling or block creation
CN101501075B (zh) * 2006-08-04 2013-07-10 诺维信生物制药丹麦公司 支化透明质酸和制造方法
US20080070993A1 (en) * 2006-09-07 2008-03-20 Janos Borbely Additives for cosmetic products and the like
FR2909285A1 (fr) * 2006-12-01 2008-06-06 Anteis Sa "utilisation d'un gel anti-adhesif et anti fibrotique"
FR2909560B1 (fr) * 2006-12-06 2012-12-28 Fabre Pierre Dermo Cosmetique Gel d'acide hyaluronique pour injection intradermique
JP2008255061A (ja) * 2007-04-06 2008-10-23 Shiseido Co Ltd 可溶性架橋ヒアルロン酸含有眼用組成物
WO2009012367A1 (en) * 2007-07-18 2009-01-22 Aesthetic Science Composition and method of use for soft tissue augmentation/drug delivery
US8563514B2 (en) * 2007-08-15 2013-10-22 Metamorefix Peptides and pharmaceutical compositions for treating connective tissue
MX2010002829A (es) 2007-09-12 2010-04-01 Digital Fountain Inc Generacion y comunicacion de informacion para identificacion de fuentes para permitir comunicaciones seguras.
CN102177180A (zh) 2008-04-04 2011-09-07 犹他州大学研究基金会 烷基化半合成的糖胺聚糖醚及其制备和使用方法
US8932622B2 (en) * 2008-06-03 2015-01-13 Actamax Surgical Materials, Llc Tissue coating for preventing undesired tissue-to-tissue adhesions
US8450475B2 (en) 2008-08-04 2013-05-28 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
KR20110042340A (ko) * 2008-08-05 2011-04-26 데이진 가부시키가이샤 하이드로겔
US20100104654A1 (en) 2008-10-27 2010-04-29 Allergan, Inc. Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
FR2938187B1 (fr) * 2008-11-07 2012-08-17 Anteis Sa Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur
US9281847B2 (en) 2009-02-27 2016-03-08 Qualcomm Incorporated Mobile reception of digital video broadcasting—terrestrial services
US9288010B2 (en) 2009-08-19 2016-03-15 Qualcomm Incorporated Universal file delivery methods for providing unequal error protection and bundled file delivery services
IT1395392B1 (it) * 2009-08-27 2012-09-14 Fidia Farmaceutici Geli viscoelastici come nuovi filler
US9917874B2 (en) 2009-09-22 2018-03-13 Qualcomm Incorporated Enhanced block-request streaming using block partitioning or request controls for improved client-side handling
JP5604072B2 (ja) * 2009-09-28 2014-10-08 テルモ株式会社 活性エステル化多糖およびその製造方法
FR2954945B1 (fr) * 2010-01-04 2012-01-06 Oreal Composition cosmetique ou dermatologique, procede de traitement cosmetique et derive d'acide hyaluronique
US20110280311A1 (en) 2010-05-13 2011-11-17 Qualcomm Incorporated One-stream coding for asymmetric stereo video
JP2013530785A (ja) * 2010-07-12 2013-08-01 シン・プーン・ファーマシューティカル・カンパニー・リミテッド 組織増大用充填組成物
US9596447B2 (en) 2010-07-21 2017-03-14 Qualcomm Incorporated Providing frame packing type information for video coding
US8806050B2 (en) 2010-08-10 2014-08-12 Qualcomm Incorporated Manifest file updates for network streaming of coded multimedia data
US8958375B2 (en) 2011-02-11 2015-02-17 Qualcomm Incorporated Framing for an improved radio link protocol including FEC
US9270299B2 (en) 2011-02-11 2016-02-23 Qualcomm Incorporated Encoding and decoding using elastic codes with flexible source block mapping
AU2012230822A1 (en) 2011-03-23 2013-11-07 University Of Utah Research Foundation Methods for treating or preventing urological inflammation
RU2477155C2 (ru) * 2011-04-27 2013-03-10 Закрытое акционерное общество "Патент-Фарм" Способ лечения андрогенетической алопеции
US9253233B2 (en) 2011-08-31 2016-02-02 Qualcomm Incorporated Switch signaling methods providing improved switching between representations for adaptive HTTP streaming
US9843844B2 (en) 2011-10-05 2017-12-12 Qualcomm Incorporated Network streaming of media data
CZ2012136A3 (cs) * 2012-02-28 2013-06-05 Contipro Biotech S.R.O. Deriváty na bázi kyseliny hyaluronové schopné tvorit hydrogely, zpusob jejich prípravy, hydrogely na bázi techto derivátu, zpusob jejich prípravy a pouzití
US9294226B2 (en) 2012-03-26 2016-03-22 Qualcomm Incorporated Universal object delivery and template-based file delivery
FR2997014B1 (fr) 2012-10-24 2015-03-20 Teoxane Composition sterile dermo-injectable
FR3005056B1 (fr) * 2013-04-24 2016-04-01 Ayawane Hydrogel a base de polysaccharides natifs et/ou fonctionnalises, phosphates co-reticules
BR112015031457A2 (pt) 2013-06-28 2017-07-25 Galderma Sa processo para preparar um produto do ácido hialurônico reticulado
US9421198B2 (en) 2013-07-30 2016-08-23 Teoxane Composition comprising hyaluronic acid and mepivacaine
ITUD20130119A1 (it) * 2013-09-12 2015-03-13 Limacorporate Spa Idrogel biocompatibile per uso biomedico o farmaceutico, polimero intermedio per realizzare detto idrogel biocompatibile e relativo metodo di realizzazione
WO2015073919A1 (en) * 2013-11-14 2015-05-21 University Medical Pharmaceuticals Corporation Microneedles for therapeutic agent delivery with improved mechanical properties
JP6081617B2 (ja) * 2014-01-31 2017-02-15 生化学工業株式会社 ジアミン架橋剤、酸性多糖架橋体、及び医用材料
PL3397651T3 (pl) 2015-12-29 2021-02-08 Galderma S.A. Węglowodanowy środek sieciujący
US11337994B2 (en) 2016-09-15 2022-05-24 University Of Utah Research Foundation In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
EP3515511A1 (en) 2016-09-21 2019-07-31 Nestlé Skin Health SA Hyaluronic acid gel with a divalent zinc cation
CN110891611B (zh) 2017-03-22 2024-03-29 阿森迪斯制药公司 水凝胶交联透明质酸前药组合物和方法
WO2019001784A1 (en) 2017-06-28 2019-01-03 Nestlé Skin Health Sa HYALURONIC ACID GEL WITH A DIVALENT CATION
CN107469090B (zh) * 2017-08-15 2020-05-12 浙江大学 可共载抗肿瘤药物和核酸药物的纳米载体及抗肿瘤药物纳米制剂
EP3659632A1 (en) 2018-11-29 2020-06-03 Nestlé Skin Health SA Post-crosslinking partial degradation of amide crosslinked hydrogels
US20220213233A1 (en) * 2019-04-19 2022-07-07 Jointherapeutics S.R.L. Crosslinked polymer of functionalized hyaluronic acid and its use in the treatment of inflammatory states
CN110123741B (zh) * 2019-06-24 2022-02-08 中国医学科学院基础医学研究所 一种铁交联透明质酸纳米凝胶、其制备方法以及用途
CN110684211B (zh) * 2019-10-14 2022-07-12 宁夏妙朗生物科技有限公司 制备抵抗α-葡萄糖苷酶水解的交联右旋糖苷凝胶的方法
KR20220110786A (ko) 2019-12-02 2022-08-09 갈더마 홀딩 소시에떼 아노님 고분자량 에스테틱 조성물
EP4247340A1 (en) 2020-11-18 2023-09-27 Bexson Biomedical, Inc. Complexing agent salt formulations of pharmaceutical compounds
WO2022109050A1 (en) * 2020-11-18 2022-05-27 Bexson Biomedical, Inc. Complexing agent salt formulations of pharmaceutical compounds
WO2023148619A1 (en) 2022-02-01 2023-08-10 Galderma Holding SA Methods of producing crosslinked hyaluronic acid hydrogels
CN114561046B (zh) * 2022-02-28 2023-10-27 江南大学 一种胍基透明质酸型抗菌水凝胶及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
RU2113221C1 (ru) * 1990-05-04 1998-06-20 Ииссум Рисерч Дивелопмент Компани оф дзе Хебрю Юниверсити оф Иеруcалим Фармацевтическая форма для введения лекарственного средства в ободочную кишку, способ введения лекарственного препарата и способ получения матриц для такой формы
DE69231155T2 (de) * 1991-08-16 2001-02-15 Miles A. Galin Mit arzneimittel überzogenes lichtbrechendes implantat für die vordere augenkammer
IT1254170B (it) * 1991-12-18 1995-09-11 Mini Ricerca Scient Tecnolog Membrane composite per la rigenerazione guidata di tessuti
CA2076732C (en) * 1992-04-17 2006-05-09 Kimberly-Clark Worldwide, Inc. Modified polysaccharides having improved absorbent properties and process for the preparation thereof
JPH06154596A (ja) * 1992-11-18 1994-06-03 Sanyo Chem Ind Ltd 耐塩安定性吸収剤及びその製法
US5616568A (en) * 1993-11-30 1997-04-01 The Research Foundation Of State University Of New York Functionalized derivatives of hyaluronic acid
JPH0959303A (ja) * 1995-08-22 1997-03-04 Shiseido Co Ltd 生体適合性ヒアルロン酸ゲル及びその用途
FR2752843B1 (fr) * 1996-08-30 1998-10-16 Sod Conseils Rech Applic Copolymeres reticules a base de polymeres polycarboxyliques et leur utilisation comme support de composition pharmaceutique
IT1303738B1 (it) * 1998-11-11 2001-02-23 Aquisitio S P A Processo di reticolazione di polisaccaridi carbossilati.

Also Published As

Publication number Publication date
IL143063A0 (en) 2002-04-21
ES2184521T5 (es) 2011-06-13
HUP0104296A2 (hu) 2002-03-28
ZA200103799B (en) 2002-08-12
CN1328573A (zh) 2001-12-26
HU229668B1 (en) 2014-04-28
RU2230752C2 (ru) 2004-06-20
HK1041011B (zh) 2004-10-08
EP1144459A2 (en) 2001-10-17
IT1303735B1 (it) 2001-02-23
CZ20011650A3 (cs) 2001-09-12
CA2350667A1 (en) 2000-05-18
DK1144459T4 (da) 2011-06-06
DK1144459T3 (da) 2003-02-03
PT1144459E (pt) 2003-01-31
NZ511306A (en) 2003-05-30
DE69903351T3 (de) 2012-02-09
DE69903351T2 (de) 2003-07-03
CN1131241C (zh) 2003-12-17
CZ296842B6 (cs) 2006-06-14
KR20010101001A (ko) 2001-11-14
ES2184521T3 (es) 2003-04-01
EP1144459B2 (en) 2011-02-23
JP2002529550A (ja) 2002-09-10
ATE225371T1 (de) 2002-10-15
NO20012315D0 (no) 2001-05-10
WO2000027887A3 (en) 2000-11-16
TR200101324T2 (tr) 2001-09-21
WO2000027887A2 (en) 2000-05-18
EP1144459B1 (en) 2002-10-02
HUP0104296A3 (en) 2003-12-29
AU757102B2 (en) 2003-01-30
HK1041011A1 (en) 2002-06-28
ITMI982440A1 (it) 2000-05-11
KR100674177B1 (ko) 2007-01-24
DE69903351D1 (de) 2002-11-07
AU2660000A (en) 2000-05-29
US6831172B1 (en) 2004-12-14
NO20012315L (no) 2001-07-06

Similar Documents

Publication Publication Date Title
BR9915235A (pt) ácidos hialurÈnicos reticulados e usos médicos dos mesmos
Thomopoulos et al. Enhanced flexor tendon healing through controlled delivery of PDGF‐BB
RU2001112488A (ru) Поперечносшитые гиалуроновые кислоты и их применение в медицине
US20220233579A1 (en) Hydrogen sulfide releasing polymer compounds
BRPI9908182C1 (pt) composições de proteína de matriz para cura de feridas
BRPI0416032A (pt) excipientes em veìculos de distribuição de fármacos
BR9711241B8 (pt) processo para fabricar uma composição polimérica para prevenir ou inibir a formação de aderências de tecidos ou para inibir sangramento
BRPI0416590A (pt) excipientes em veìculos de distribuição de fármacos
DE69013833D1 (de) Zusammensetzung und methode zur verhütung von verklebungen zwischen körpergewebe.
PT1061900E (pt) Composicoes e metodos para libertacao de uma droga
BRPI0418309B8 (pt) &#34;géis coesos de hialuronado e/ou hilano reticulados, processo para a preparação dos mesmos, bem como composições e dispositivos compreendendo os referidos géis&#34;.
ES2163034T3 (es) Composiciones micelares de copolimeros de bloque de polieter, para la objetivizacion de agentes biologicos como diana.
WO2004073759A1 (en) Composition and method for intradermal soft tissue augmentation
BRPI0511603A (pt) método para o tratamento de distúrbios do sangramento com a utilização de polissacarìdeos sulfatados
ES2158611T3 (es) Composicion en gel inyectable con efecto retard y procedimiento para la preparacion de dicha composicion.
WO2002039948A3 (en) Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants
BR0115531A (pt) Tratamento de mucosites
BRPI0509332A (pt) implantes oculares biodegradáveis com caracterìsticas de liberação a longo prazo
BR0016336A (pt) Combinações de substâncias ativas fungicidas
EA200802307A1 (ru) Бинарные смеси гиалуроновой кислоты и их терапевтическое применение
MX2007005509A (es) Composicion y viscoelastica de polimero natural triple.
JP2018504984A5 (pt)
CN102481313A (zh) 抑制疼痛的药物组合物
DE60313356D1 (de) Verwendungvon dextransulfat zur behandlung von ibmir
EP3419590B1 (en) Hyaluronic acid conjugate

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Free format text: FARMILA-THEA FARMACEUTICI S.P.A. (IT)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: SIGMA ITALIA S.P.A. (IT)

Free format text: TRANSFERIDO DE: FARMILA-THEA FARMACEUTICI S.P.A.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A,11A E 12A ANUIDADE(S).

B25K Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: republication

Owner name: SIGMAR ITALIA S.P.A. (IT)

Free format text: RETIFICACAO DO DESPACHO 25.1 PUBLICADO NA RPI NO 1939, DE 04/03/2008, QUANTO AO ITEM (71) - NOME DODEPOSITANTE. ONDE SE LE: SIGMA ITALIA S.P.A.; LEIA-SE: SIGMAR ITALIA S.P.A.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE AS 10A, 11A E 12A ANUIDADES.